nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP19A1—polycystic ovary syndrome	0.642	1	CbGaD
Raloxifene—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0301	0.185	CbGeAlD
Raloxifene—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0173	0.106	CbGeAlD
Raloxifene—ESR2—ovarian follicle—polycystic ovary syndrome	0.0172	0.106	CbGeAlD
Raloxifene—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0136	0.0832	CbGeAlD
Raloxifene—ESR1—ovarian follicle—polycystic ovary syndrome	0.0118	0.0723	CbGeAlD
Raloxifene—EBP—uterus—polycystic ovary syndrome	0.0045	0.0276	CbGeAlD
Raloxifene—EBP—endocrine gland—polycystic ovary syndrome	0.00343	0.021	CbGeAlD
Raloxifene—CYP3A4—urine—polycystic ovary syndrome	0.00275	0.0169	CbGeAlD
Raloxifene—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00204	0.113	CcSEcCtD
Raloxifene—AOX1—adrenal cortex—polycystic ovary syndrome	0.00183	0.0113	CbGeAlD
Raloxifene—ESR2—endometrium—polycystic ovary syndrome	0.0017	0.0104	CbGeAlD
Raloxifene—AOX1—endometrium—polycystic ovary syndrome	0.00164	0.0101	CbGeAlD
Raloxifene—ESR1—embryo—polycystic ovary syndrome	0.00159	0.00977	CbGeAlD
Raloxifene—ESR2—uterus—polycystic ovary syndrome	0.00157	0.00962	CbGeAlD
Raloxifene—ESR2—pituitary gland—polycystic ovary syndrome	0.00154	0.00945	CbGeAlD
Raloxifene—AOX1—uterus—polycystic ovary syndrome	0.00151	0.00926	CbGeAlD
Raloxifene—AOX1—pituitary gland—polycystic ovary syndrome	0.00148	0.0091	CbGeAlD
Raloxifene—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.00148	0.00906	CbGeAlD
Raloxifene—AOX1—adipose tissue—polycystic ovary syndrome	0.00148	0.00906	CbGeAlD
Raloxifene—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00147	0.00904	CbGeAlD
Raloxifene—ESR2—adrenal gland—polycystic ovary syndrome	0.00138	0.00844	CbGeAlD
Raloxifene—CYP19A1—endometrium—polycystic ovary syndrome	0.00134	0.00823	CbGeAlD
Raloxifene—AOX1—adrenal gland—polycystic ovary syndrome	0.00132	0.00813	CbGeAlD
Raloxifene—SIGMAR1—endometrium—polycystic ovary syndrome	0.00132	0.00809	CbGeAlD
Raloxifene—HTR2B—endometrium—polycystic ovary syndrome	0.00132	0.00807	CbGeAlD
Raloxifene—ESR2—female gonad—polycystic ovary syndrome	0.00128	0.00787	CbGeAlD
Raloxifene—ESR2—vagina—polycystic ovary syndrome	0.00128	0.00782	CbGeAlD
Raloxifene—CYP19A1—uterus—polycystic ovary syndrome	0.00124	0.00758	CbGeAlD
Raloxifene—AOX1—female gonad—polycystic ovary syndrome	0.00124	0.00758	CbGeAlD
Raloxifene—AOX1—vagina—polycystic ovary syndrome	0.00123	0.00753	CbGeAlD
Raloxifene—SIGMAR1—uterus—polycystic ovary syndrome	0.00122	0.00746	CbGeAlD
Raloxifene—HTR2B—uterus—polycystic ovary syndrome	0.00121	0.00744	CbGeAlD
Raloxifene—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00121	0.00742	CbGeAlD
Raloxifene—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.00119	0.00732	CbGeAlD
Raloxifene—ESR2—endocrine gland—polycystic ovary syndrome	0.00119	0.00732	CbGeAlD
Raloxifene—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.00119	0.00729	CbGeAlD
Raloxifene—HTR2B—adipose tissue—polycystic ovary syndrome	0.00119	0.00728	CbGeAlD
Raloxifene—ESR1—endometrium—polycystic ovary syndrome	0.00117	0.00715	CbGeAlD
Raloxifene—AOX1—endocrine gland—polycystic ovary syndrome	0.00115	0.00705	CbGeAlD
Raloxifene—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00108	0.00665	CbGeAlD
Raloxifene—ESR1—uterus—polycystic ovary syndrome	0.00107	0.00659	CbGeAlD
Raloxifene—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.00107	0.00654	CbGeAlD
Raloxifene—HTR2B—adrenal gland—polycystic ovary syndrome	0.00106	0.00653	CbGeAlD
Raloxifene—ESR1—pituitary gland—polycystic ovary syndrome	0.00106	0.00647	CbGeAlD
Raloxifene—ESR1—adipose tissue—polycystic ovary syndrome	0.00105	0.00645	CbGeAlD
Raloxifene—CYP19A1—female gonad—polycystic ovary syndrome	0.00101	0.0062	CbGeAlD
Raloxifene—SIGMAR1—female gonad—polycystic ovary syndrome	0.000994	0.0061	CbGeAlD
Raloxifene—SIGMAR1—vagina—polycystic ovary syndrome	0.000988	0.00606	CbGeAlD
Raloxifene—HTR2B—vagina—polycystic ovary syndrome	0.000986	0.00605	CbGeAlD
Raloxifene—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000965	0.00592	CbGeAlD
Raloxifene—CYP2C8—endometrium—polycystic ovary syndrome	0.00096	0.00589	CbGeAlD
Raloxifene—ESR1—adrenal gland—polycystic ovary syndrome	0.000942	0.00578	CbGeAlD
Raloxifene—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00094	0.00577	CbGeAlD
Raloxifene—ESR1—female gonad—polycystic ovary syndrome	0.000879	0.00539	CbGeAlD
Raloxifene—ESR1—vagina—polycystic ovary syndrome	0.000873	0.00536	CbGeAlD
Raloxifene—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000869	0.00533	CbGeAlD
Raloxifene—Migraine—Metformin—polycystic ovary syndrome	0.000855	0.0475	CcSEcCtD
Raloxifene—ESR1—endocrine gland—polycystic ovary syndrome	0.000817	0.00501	CbGeAlD
Raloxifene—Breast disorder—Metformin—polycystic ovary syndrome	0.000785	0.0437	CcSEcCtD
Raloxifene—Influenza—Metformin—polycystic ovary syndrome	0.000751	0.0417	CcSEcCtD
Raloxifene—CYP2C8—vagina—polycystic ovary syndrome	0.00072	0.00441	CbGeAlD
Raloxifene—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000696	0.00427	CbGeAlD
Raloxifene—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000673	0.00413	CbGeAlD
Raloxifene—CYP2B6—vagina—polycystic ovary syndrome	0.000645	0.00396	CbGeAlD
Raloxifene—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000604	0.0037	CbGeAlD
Raloxifene—Rhinitis—Metformin—polycystic ovary syndrome	0.000603	0.0335	CcSEcCtD
Raloxifene—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000598	0.0332	CcSEcCtD
Raloxifene—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000592	0.0329	CcSEcCtD
Raloxifene—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000591	0.0328	CcSEcCtD
Raloxifene—Flushing—Metformin—polycystic ovary syndrome	0.000558	0.031	CcSEcCtD
Raloxifene—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000558	0.031	CcSEcCtD
Raloxifene—Angiopathy—Metformin—polycystic ovary syndrome	0.000545	0.0303	CcSEcCtD
Raloxifene—Flatulence—Metformin—polycystic ovary syndrome	0.000516	0.0287	CcSEcCtD
Raloxifene—Muscle spasms—Metformin—polycystic ovary syndrome	0.000503	0.028	CcSEcCtD
Raloxifene—Syncope—Metformin—polycystic ovary syndrome	0.000469	0.0261	CcSEcCtD
Raloxifene—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00046	0.0256	CcSEcCtD
Raloxifene—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000456	0.0028	CbGeAlD
Raloxifene—Myalgia—Metformin—polycystic ovary syndrome	0.000445	0.0248	CcSEcCtD
Raloxifene—Chest pain—Metformin—polycystic ovary syndrome	0.000445	0.0248	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000442	0.0246	CcSEcCtD
Raloxifene—Infection—Metformin—polycystic ovary syndrome	0.000424	0.0236	CcSEcCtD
Raloxifene—Shock—Metformin—polycystic ovary syndrome	0.00042	0.0234	CcSEcCtD
Raloxifene—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000419	0.0233	CcSEcCtD
Raloxifene—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000418	0.0232	CcSEcCtD
Raloxifene—Skin disorder—Metformin—polycystic ovary syndrome	0.000415	0.0231	CcSEcCtD
Raloxifene—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000413	0.023	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000389	0.0216	CcSEcCtD
Raloxifene—Dyspepsia—Metformin—polycystic ovary syndrome	0.000376	0.0209	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000369	0.0205	CcSEcCtD
Raloxifene—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000349	0.0194	CcSEcCtD
Raloxifene—Abdominal pain—Metformin—polycystic ovary syndrome	0.000338	0.0188	CcSEcCtD
Raloxifene—Diarrhoea—Metformin—polycystic ovary syndrome	0.000292	0.0162	CcSEcCtD
Raloxifene—Dizziness—Metformin—polycystic ovary syndrome	0.000282	0.0157	CcSEcCtD
Raloxifene—Vomiting—Metformin—polycystic ovary syndrome	0.000272	0.0151	CcSEcCtD
Raloxifene—Rash—Metformin—polycystic ovary syndrome	0.000269	0.015	CcSEcCtD
Raloxifene—Dermatitis—Metformin—polycystic ovary syndrome	0.000269	0.015	CcSEcCtD
Raloxifene—Headache—Metformin—polycystic ovary syndrome	0.000268	0.0149	CcSEcCtD
Raloxifene—Nausea—Metformin—polycystic ovary syndrome	0.000254	0.0141	CcSEcCtD
Raloxifene—HTR2B—Signaling Pathways—FST—polycystic ovary syndrome	3.69e-05	0.000208	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	3.67e-05	0.000207	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.67e-05	0.000207	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.65e-05	0.000206	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.65e-05	0.000206	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LHB—polycystic ovary syndrome	3.61e-05	0.000203	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.57e-05	0.000201	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP1A1—polycystic ovary syndrome	3.55e-05	0.0002	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.53e-05	0.000199	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.52e-05	0.000199	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.51e-05	0.000198	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.5e-05	0.000197	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	3.48e-05	0.000197	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF18—polycystic ovary syndrome	3.47e-05	0.000196	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	3.45e-05	0.000195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RBP4—polycystic ovary syndrome	3.44e-05	0.000194	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	3.44e-05	0.000194	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.41e-05	0.000193	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.41e-05	0.000192	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.39e-05	0.000191	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	3.39e-05	0.000191	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SCT—polycystic ovary syndrome	3.38e-05	0.000191	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.34e-05	0.000188	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	3.32e-05	0.000188	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.32e-05	0.000187	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.31e-05	0.000187	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTHFR—polycystic ovary syndrome	3.31e-05	0.000187	CbGpPWpGaD
Raloxifene—AOX1—Disease—IRS1—polycystic ovary syndrome	3.28e-05	0.000185	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PGR—polycystic ovary syndrome	3.28e-05	0.000185	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	3.26e-05	0.000184	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.25e-05	0.000183	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.22e-05	0.000182	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—YAP1—polycystic ovary syndrome	3.21e-05	0.000181	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—PPARG—polycystic ovary syndrome	3.17e-05	0.000179	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GAB1—polycystic ovary syndrome	3.17e-05	0.000179	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF18—polycystic ovary syndrome	3.17e-05	0.000179	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.16e-05	0.000178	CbGpPWpGaD
Raloxifene—AOX1—Disease—INS—polycystic ovary syndrome	3.14e-05	0.000177	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RBP4—polycystic ovary syndrome	3.14e-05	0.000177	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	3.14e-05	0.000177	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.13e-05	0.000177	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.13e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.12e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	3.11e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.1e-05	0.000175	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.09e-05	0.000175	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.09e-05	0.000174	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	3.08e-05	0.000174	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.07e-05	0.000173	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.04e-05	0.000172	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT2—polycystic ovary syndrome	3.04e-05	0.000171	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INSR—polycystic ovary syndrome	3.03e-05	0.000171	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	3e-05	0.000169	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.99e-05	0.000169	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	2.96e-05	0.000167	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	2.95e-05	0.000166	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.94e-05	0.000166	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.93e-05	0.000165	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.92e-05	0.000165	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.89e-05	0.000163	CbGpPWpGaD
Raloxifene—AOX1—Disease—SERPINE1—polycystic ovary syndrome	2.89e-05	0.000163	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.88e-05	0.000162	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.88e-05	0.000162	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SERPINE1—polycystic ovary syndrome	2.86e-05	0.000161	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.84e-05	0.00016	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.83e-05	0.00016	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	2.83e-05	0.000159	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	2.81e-05	0.000159	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	2.81e-05	0.000159	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PGR—polycystic ovary syndrome	2.81e-05	0.000158	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.78e-05	0.000157	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INSR—polycystic ovary syndrome	2.77e-05	0.000156	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.76e-05	0.000156	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.68e-05	0.000151	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PPARG—polycystic ovary syndrome	2.68e-05	0.000151	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—POMC—polycystic ovary syndrome	2.65e-05	0.000149	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.64e-05	0.000149	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—INS—polycystic ovary syndrome	2.63e-05	0.000149	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.63e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.62e-05	0.000148	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PLAT—polycystic ovary syndrome	2.61e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GHRL—polycystic ovary syndrome	2.61e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.59e-05	0.000146	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	2.58e-05	0.000145	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PGR—polycystic ovary syndrome	2.56e-05	0.000144	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AR—polycystic ovary syndrome	2.55e-05	0.000144	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.52e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.52e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	2.52e-05	0.000142	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.51e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	2.51e-05	0.000141	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.49e-05	0.000141	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ATF1—polycystic ovary syndrome	2.49e-05	0.00014	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.44e-05	0.000138	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	2.44e-05	0.000138	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.43e-05	0.000137	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.42e-05	0.000137	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.41e-05	0.000136	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.41e-05	0.000136	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.39e-05	0.000135	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.38e-05	0.000134	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.38e-05	0.000134	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.36e-05	0.000133	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.34e-05	0.000132	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.34e-05	0.000132	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	2.3e-05	0.00013	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NGFR—polycystic ovary syndrome	2.3e-05	0.00013	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.29e-05	0.000129	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—POMC—polycystic ovary syndrome	2.28e-05	0.000129	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PRL—polycystic ovary syndrome	2.28e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.27e-05	0.000128	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	2.24e-05	0.000127	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.24e-05	0.000126	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	2.23e-05	0.000126	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.21e-05	0.000125	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.2e-05	0.000124	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.19e-05	0.000124	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.19e-05	0.000123	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	2.18e-05	0.000123	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	2.17e-05	0.000123	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.16e-05	0.000122	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.15e-05	0.000122	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	2.13e-05	0.00012	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	2.13e-05	0.00012	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NGFR—polycystic ovary syndrome	2.1e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	2.1e-05	0.000118	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—POMC—polycystic ovary syndrome	2.08e-05	0.000118	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRL—polycystic ovary syndrome	2.08e-05	0.000117	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	2.06e-05	0.000117	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	2.06e-05	0.000116	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	2.03e-05	0.000115	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	2.01e-05	0.000114	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	2e-05	0.000113	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GNAS—polycystic ovary syndrome	2e-05	0.000113	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.99e-05	0.000112	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.99e-05	0.000112	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	1.99e-05	0.000112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.98e-05	0.000112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.98e-05	0.000112	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.97e-05	0.000111	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.94e-05	0.000109	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.91e-05	0.000108	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.9e-05	0.000107	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.89e-05	0.000107	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	1.88e-05	0.000106	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NRG1—polycystic ovary syndrome	1.87e-05	0.000106	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	1.85e-05	0.000104	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.84e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.84e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.84e-05	0.000104	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.83e-05	0.000103	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.77e-05	0.0001	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.75e-05	9.85e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.74e-05	9.82e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	1.73e-05	9.76e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.71e-05	9.66e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.71e-05	9.64e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.7e-05	9.62e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.69e-05	9.56e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.68e-05	9.5e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.67e-05	9.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.67e-05	9.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.64e-05	9.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS2—polycystic ovary syndrome	1.6e-05	9.05e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.6e-05	9.02e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	1.6e-05	9.02e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.59e-05	8.97e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.58e-05	8.93e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—polycystic ovary syndrome	1.57e-05	8.85e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.56e-05	8.83e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.56e-05	8.78e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.52e-05	8.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.51e-05	8.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.46e-05	8.26e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	1.46e-05	8.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.45e-05	8.18e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.44e-05	8.12e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.43e-05	8.08e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.42e-05	8.03e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS1—polycystic ovary syndrome	1.4e-05	7.9e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.39e-05	7.83e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—polycystic ovary syndrome	1.37e-05	7.75e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.37e-05	7.72e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.36e-05	7.68e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.35e-05	7.64e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—polycystic ovary syndrome	1.35e-05	7.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.35e-05	7.59e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INS—polycystic ovary syndrome	1.34e-05	7.56e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	7.43e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.31e-05	7.37e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—polycystic ovary syndrome	1.3e-05	7.31e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT2—polycystic ovary syndrome	1.3e-05	7.31e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.28e-05	7.24e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.28e-05	7.21e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.24e-05	7.02e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.24e-05	6.99e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.23e-05	6.95e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.23e-05	6.94e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	1.22e-05	6.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.22e-05	6.88e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.19e-05	6.73e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.18e-05	6.68e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.18e-05	6.67e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.18e-05	6.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.17e-05	6.61e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.14e-05	6.46e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.12e-05	6.34e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.11e-05	6.25e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	6.24e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.1e-05	6.2e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.06e-05	6e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	5.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	1.02e-05	5.78e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.02e-05	5.76e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	1.02e-05	5.75e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	9.98e-06	5.63e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	9.91e-06	5.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.88e-06	5.57e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.86e-06	5.56e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.85e-06	5.56e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.52e-06	5.37e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.36e-06	5.28e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	9.31e-06	5.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.15e-06	5.16e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	9.05e-06	5.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	9.04e-06	5.1e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	8.91e-06	5.03e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	8.79e-06	4.96e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—INS—polycystic ovary syndrome	8.74e-06	4.93e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.53e-06	4.81e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.47e-06	4.78e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.4e-06	4.74e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.73e-06	4.36e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	7.55e-06	4.26e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	7.44e-06	4.2e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—INS—polycystic ovary syndrome	7.4e-06	4.18e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.27e-06	4.1e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.07e-06	3.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.65e-06	3.75e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.44e-06	3.63e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.93e-06	3.35e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	5.86e-06	3.3e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.65e-06	3.19e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.36e-06	3.02e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	5.35e-06	3.02e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5e-06	2.82e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	4.45e-06	2.51e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.05e-06	2.29e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4e-06	2.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.97e-06	2.24e-05	CbGpPWpGaD
